查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386582

計算生物學市場報告：2030 年趨勢、預測與競爭分析

Computational Biology Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

計算生物學的趨勢和預測

預計到 2030 年，全球計算生物學市場將達到 128 億美元，2024 年至 2030 年年複合成長率為 13.4%。該市場的主要驅動力是基於人工智慧的技術在藥物研發中的日益使用以及對藥物設計和疾病建模的興趣日益濃厚。全球計算生物學市場的未來充滿了學術、研究和商業機會。

計算生物學市場洞察

Lucintel 預測，細胞和生物模擬將在預測期內達到最高成長。

由於公共和私營部門在基因工程和開發新藥方面的研發支出增加，預計在預測期內商業部門的市場將出現更高的成長。

由於擁有強大的醫療基礎設施、不斷增加的慢性疾病患者數量以及主要參與者的存在，北美仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球計算生物學市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球計算生物學市場趨勢（2018-2023）與預測（2024-2030）
  • 全球計算生物學市場（按服務）
    • 合約
    • 公司內部
  • 全球計算生物學市場（按應用）
    • 細胞和生物模擬
    • 藥物研發與疾病建模
    • 臨床前藥物開發
    • 臨床試驗
    • 人體模擬軟體
    • 其他
  • 按最終用途行業分類的全球計算生物學市場
    • 學術與研究
    • 商業的
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球計算生物學市場（按地區）
  • 北美計算生物學市場
  • 歐洲計算生物學市場
  • 亞太計算生物學市場
  • 其他區域計算生物學市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球計算生物學市場成長機會（按服務）
    • 全球計算生物學市場成長機會（按應用）
    • 最終用途產業的全球計算生物學市場成長機會
    • 按地區分類的全球計算生物學市場成長機會
  • 全球計算生物學市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球計算生物學市場的容量
    • 全球計算生物學市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Genedata
  • Rhenovia Pharma
  • Compugen
  • Chemical Computing
  • Certara
  • Nimbus Discovery
  • Rhenovia Pharma & Leadscope
  • Simulation Plus
  • Entelos
  • Insilico Biotechnology
簡介目錄

Computational Biology Trends and Forecast

The future of the global computational biology market looks promising with opportunities in the academic & research and commercial sectors. The global computational biology market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 13.4% from 2024 to 2030. The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.

A more than 150-page report is developed to help in your business decisions.

Computational Biology by Segment

The study includes a forecast for the global computational biology by service, application, end use industry, and region.

Computational Biology Market by Service [Shipment Analysis by Value from 2018 to 2030]:

  • Contract
  • In-House

Computational Biology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cellular & Biological Simulation
  • Drug Discovery & Disease Modelling
  • Preclinical Drug Development
  • Clinical Trials
  • Human Body Simulation Software
  • Others

Computational Biology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Academics & Research
  • Commercial
  • Others

Computational Biology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Computational Biology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies computational biology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the computational biology companies profiled in this report include-

  • Genedata
  • Rhenovia Pharma
  • Compugen
  • Chemical Computing
  • Certara
  • Nimbus Discovery
  • Rhenovia Pharma & Leadscope
  • Simulation Plus
  • Entelos
  • Insilico Biotechnology

Computational Biology Market Insights

Lucintel forecasts that cellular & biological simulation is expected to witness highest growth over the forecast period.

Within this market, commercial is expected to witness higher growth over the forecast period due to increasing public and private sector spending on research and development in genetic engineering and the development of new drugs.

North America will remain the largest region due to existence of robust healthcare infrastructure, growing cases of chronic disease, and presence of key players in the region.

Features of the Global Computational Biology Market

Market Size Estimates: Computational biology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Computational biology market size by service, application, end use industry, and region in terms of value ($B).

Regional Analysis: Computational biology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different services, applications, end use industries, and regions for the computational biology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the computational biology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the computational biology market size?

Answer: The global computational biology market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for computational biology market?

Answer: The global computational biology market is expected to grow with a CAGR of 13.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the computational biology market?

Answer: The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.

Q4. What are the major segments for computational biology market?

Answer: The future of the computational biology market looks promising with opportunities in the academic & research and commercial sectors.

Q5. Who are the key computational biology market companies?

Answer: Some of the key computational biology companies are as follows:

  • Genedata
  • Rhenovia Pharma
  • Compugen
  • Chemical Computing
  • Certara
  • Nimbus Discovery
  • Rhenovia Pharma & Leadscope
  • Simulation Plus
  • Entelos
  • Insilico Biotechnology

Q6. Which computational biology market segment will be the largest in future?

Answer: Lucintel forecasts that cellular & biological simulation is expected to witness highest growth over the forecast period.

Q7. In computational biology market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, growing cases of chronic disease, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the computational biology market by service (contract and in-house), application (cellular & biological simulation, drug discovery & disease modelling, preclinical drug development, clinical trials, human body simulation software, and others), end use industry (academics & research, commercial, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Computational Biology Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Computational Biology Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Computational Biology Market by Service
    • 3.3.1: Contract
    • 3.3.2: In-house
  • 3.4: Global Computational Biology Market by Application
    • 3.4.1: Cellular & Biological Simulation
    • 3.4.2: Drug Discovery & Disease Modelling
    • 3.4.3: Preclinical Drug Development
    • 3.4.4: Clinical Trials
    • 3.4.5: Human Body Simulation Software
    • 3.4.6: Others
  • 3.5: Global Computational Biology Market by End Use Industry
    • 3.5.1: Academics & Research
    • 3.5.2: Commercial
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Computational Biology Market by Region
  • 4.2: North American Computational Biology Market
    • 4.2.1: North American Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
    • 4.2.2: North American Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
  • 4.3: European Computational Biology Market
    • 4.3.1: European Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
    • 4.3.2: European Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
  • 4.4: APAC Computational Biology Market
    • 4.4.1: APAC Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
    • 4.4.2: APAC Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
  • 4.5: ROW Computational Biology Market
    • 4.5.1: ROW Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
    • 4.5.2: ROW Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Computational Biology Market by Service
    • 6.1.2: Growth Opportunities for the Global Computational Biology Market by Application
    • 6.1.3: Growth Opportunities for the Global Computational Biology Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Computational Biology Market by Region
  • 6.2: Emerging Trends in the Global Computational Biology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Computational Biology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Computational Biology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Genedata
  • 7.2: Rhenovia Pharma
  • 7.3: Compugen
  • 7.4: Chemical Computing
  • 7.5: Certara
  • 7.6: Nimbus Discovery
  • 7.7: Rhenovia Pharma & Leadscope
  • 7.8: Simulation Plus
  • 7.9: Entelos
  • 7.10: Insilico Biotechnology